IDEXX Laboratories, Inc. (IDXX)
Stock Price Chart
Key Info
| Market Cap | 36.37B |
| Revenue (ttm) | 2.47B |
| Net Income (ttm) | 460.10M |
| Shares Out | 85.05M |
| EPS (ttm) | 5.29 |
| PE Ratio | 80.84 |
| Forward PE | 69.93 |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 26, 2020 |
| Last Price | $427.66 |
| Previous Close | $429.66 |
| Change ($) | -2.00 |
| Change (%) | -0.47% |
| Day's Open | 427.67 |
| Day's Range | 426.84 - 434.93 |
| Day's Volume | 182,216 |
| 52-Week Range | 168.65 - 434.93 |
More Stats
| Market Cap | 36.37B |
| Enterprise Value | 37.36B |
| Earnings Date (est) | Oct 29, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 85.05M |
| Float | 83.99M |
| EPS (basic) | 5.38 |
| EPS (diluted) | 5.29 |
| FCF / Share | 4.31 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 1.24% |
| FCF Yield | 1.01% |
| Payout Ratio | n/a |
| Shares Short | 1.25M |
| Short Ratio | 2.68 |
| Short % of Float | 1.49% |
| Beta | 0.81 |
| PE Ratio | 80.84 |
| Forward PE | 69.93 |
| P/FCF Ratio | 99.07 |
| PS Ratio | 14.70 |
| PB Ratio | 133.88 |
| Revenue | 2.47B |
| Operating Income | 593.01M |
| Net Income | 460.10M |
| Free Cash Flow | 367.15M |
| Net Cash | -984.46M |
| Net Cash / Share | -11.57 |
| Gross Margin | 55.18% |
| Operating Margin | 23.96% |
| Profit Margin | 18.60% |
| FCF Margin | 14.84% |
| ROA | 20.57% |
| ROE | 206.87% |
| ROIC | 31.40% |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,407 | 2,213 | 1,969 | 1,775 | 1,602 | 1,486 | 1,377 | 1,293 | 1,219 | 1,103 |
| Revenue Growth | 8.75% | 12.4% | 10.91% | 10.83% | 7.81% | 7.9% | 6.47% | 6.13% | 10.45% | - |
| Gross Profit | 1,366 | 1,242 | 1,097 | 975 | 890 | 816 | 756 | 699 | 647 | 579 |
| Operating Income | 553 | 491 | 413 | 350 | 300 | 260 | 267 | 263 | 236 | 204 |
| Net Income | 428 | 377 | 263 | 222 | 192 | 182 | 188 | 178 | 162 | 141 |
| Shares Outstanding | 86.12 | 86.86 | 87.77 | 89.73 | 92.60 | 100 | 106 | 110 | 114 | 115 |
| Earnings Per Share | 4.89 | 4.26 | 2.94 | 2.44 | 2.05 | 1.79 | 1.74 | 1.59 | 1.39 | 1.19 |
| EPS Growth | 14.79% | 44.9% | 20.49% | 19.02% | 14.53% | 2.87% | 9.78% | 14.03% | 17.3% | - |
| Operating Cash Flow | 459 | 400 | 373 | 339 | 222 | 236 | 246 | 222 | 218 | 179 |
| Capital Expenditures | -155 | -116 | -74.38 | -64.79 | -82.92 | -60.70 | -78.64 | -58.47 | -50.45 | -39.19 |
| Free Cash Flow | 304 | 284 | 299 | 274 | 139 | 175 | 167 | 164 | 167 | 140 |
| Cash & Equivalents | 90.33 | 124 | 472 | 392 | 343 | 323 | 279 | 224 | 184 | 157 |
| Total Debt | 1,055 | 1,000 | 1,261 | 1,204 | 1,170 | 899 | 428 | 215 | 246 | 133 |
| Net Cash / Debt | -965 | -876 | -789 | -812 | -828 | -576 | -149 | 9.49 | -62.52 | 23.64 |
| Assets | 1,832 | 1,537 | 1,713 | 1,531 | 1,475 | 1,384 | 1,231 | 1,104 | 1,031 | 897 |
| Liabilities | 1,655 | 1,547 | 1,767 | 1,639 | 1,559 | 1,267 | 712 | 467 | 491 | 323 |
| Book Value | 177 | -9.51 | -54.11 | -108 | -84.13 | 118 | 518 | 636 | 540 | 574 |
Company Profile
Company Details
| Full Name | IDEXX Laboratories, Inc. |
| Country | United States |
| Employees | 9,000 |
| CEO | Jonathan J. Mazelsky |
Stock Information
| Ticker Symbol | IDXX |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Unique Identifier | NASDAQ: IDXX |
| IPO Date | June 21, 1991 |
Description
IDEXX Laboratories, together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.